These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28544277)

  • 1. Use of a vascular closure device during percutaneous arterial access in a dog with impaired hemostasis.
    Scansen BA; Hokanson CM; Friedenberg SG; Khabiri H
    J Vet Emerg Crit Care (San Antonio); 2017 Jul; 27(4):465-471. PubMed ID: 28544277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of manual compression, Z-stitch, and suture-mediated vascular closure device techniques in dogs undergoing percutaneous transvenous intervention.
    Fabella A; Markovic LE; Coleman AE
    J Vet Cardiol; 2024 Feb; 51():124-137. PubMed ID: 38128418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.
    Schulz-Schüpke S; Helde S; Gewalt S; Ibrahim T; Linhardt M; Haas K; Hoppe K; Böttiger C; Groha P; Bradaric C; Schmidt R; Bott-Flügel L; Ott I; Goedel J; Byrne RA; Schneider S; Burgdorf C; Morath T; Kufner S; Joner M; Cassese S; Hoppmann P; Hengstenberg C; Pache J; Fusaro M; Massberg S; Mehilli J; Schunkert H; Laugwitz KL; Kastrati A;
    JAMA; 2014 Nov; 312(19):1981-7. PubMed ID: 25399273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
    Wong SC; Bachinsky W; Cambier P; Stoler R; Aji J; Rogers JH; Hermiller J; Nair R; Hutman H; Wang H;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):785-93. PubMed ID: 19695549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
    Xhepa E; Byrne RA; Schulz S; Helde S; Gewalt S; Cassese S; Linhardt M; Ibrahim T; Mehilli J; Hoppe K; Grupp K; Kufner S; Böttiger C; Hoppmann P; Burgdorf C; Fusaro M; Ott I; Schneider S; Hengstenberg C; Schunkert H; Laugwitz KL; Kastrati A;
    EuroIntervention; 2014 Jun; 10(2):198-203. PubMed ID: 24952057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and time-to-hemostasis of antegrade femoral access closure using the ExoSeal vascular closure device: a retrospective single-center study.
    Boschewitz JM; Pieper CC; Andersson M; Nadal J; Schild HH; Meyer C
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):585-91. PubMed ID: 25201516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Randomized Controlled Trials Comparing Manual Compression to Vascular Closure Devices for Diagnostic and Therapeutic Arterial Procedures.
    Cox T; Blair L; Huntington C; Lincourt A; Sing R; Heniford BT
    Surg Technol Int; 2015 Nov; 27():32-44. PubMed ID: 26680377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial access-site complications after use of a vascular closure device related to puncture height.
    Sartorius B; Behnes M; Ünsal M; Hoffmann U; Lang S; Mashayekhi K; Borggrefe M; Akin I
    BMC Cardiovasc Disord; 2017 Feb; 17(1):64. PubMed ID: 28209184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
    Kahlert P; Al-Rashid F; Plicht B; Konorza T; Neumann T; Thielmann M; Wendt D; Erbel R; Eggebrecht H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):E139-50. PubMed ID: 22553193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FemoSeal
    Gabrielli R; Rosati MS; Millarelli M; Dante A; Maiorano M; Musilli A; Chiappa R; Ventura M
    Ann Vasc Surg; 2018 Aug; 51():18-24. PubMed ID: 29678650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the FemoSeal Vascular Closure Device With Manual Compression After Femoral Artery Puncture - Post-hoc Analysis of a Large-Scale, Randomized Clinical Trial.
    Mankerious N; Mayer K; Gewalt SM; Helde SM; Ibrahim T; Bott-Flügel L; Laugwitz KL; Schunkert H; Kastrati A; Schüpke S;
    J Invasive Cardiol; 2018 Jul; 30(7):235-239. PubMed ID: 29760286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience.
    Boschewitz JM; Andersson M; Naehle CP; Schild HH; Wilhelm K; Meyer C
    J Vasc Interv Radiol; 2013 May; 24(5):698-702. PubMed ID: 23622041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model.
    Srivatsa SS; Srivatsa A; Spangler TA
    J Invasive Cardiol; 2015 Feb; 27(2):121-7. PubMed ID: 25661765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.
    Jaff MR; Hadley G; Hermiller JB; Simonton C; Hinohara T; Cannon L; Reisman M; Braden G; Fletcher DR; Zapien M; Chou TM; DiDonato K
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):684-9. PubMed ID: 17039509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan hemostatic dressing for control of hemorrhage from femoral arterial puncture site in dogs.
    Szatmári V
    J Vet Sci; 2015; 16(4):517-23. PubMed ID: 26119165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.
    Grandhi R; Zhang X; Panczykowski D; Choi P; Hunnicutt CT; Jadhav AP; Ducruet AF; Jovin T; Jankowitz B
    Interv Neuroradiol; 2015 Jun; 21(3):401-6. PubMed ID: 26015532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of StarClose SE Vascular Closure System in high-risk liver interventional oncology patients.
    Gaba RC; Parvinian A; Trinos EM; Padayao SV; Francisco RM; Yap FY; Knuttinen MG; Owens CA; Bui JT
    J Vasc Access; 2012; 13(4):415-20. PubMed ID: 22467152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.
    Benham E; Deloose K; Callaert J; Bosiers M; Cox T; Lincourt A; Heniford BT
    Surg Technol Int; 2017 Oct; 31():93-99. PubMed ID: 29020709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AbsorbaSeal™ 5.6.7F vascular closure device: A good laboratory practice chronic study evaluating safety and efficacy in a healthy porcine model.
    Ayuso SA; Shipp RC; Aladegbami BG; Farquharson D; Lawson D; Bassett R
    Vascular; 2022 Oct; 30(5):934-942. PubMed ID: 34459306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.